Orphan designation for Tetrofosmin
20/10/16 16:26 Filed in: announcement | Press
The consortium is pleased to announce that, on 14/10/2016 the European Commission has granted to proACTINA SA, Orphan Designation for tetrofosmin for the diagnosis of Glioma, following positive opinion by EMA. The product is registered in the “Community register of orphan medicinal products” with an EU orphan designation number: EU/3/16/1764.
This achievement has been one of the major milestones in GLIOMARK project.
See here the related press release.
This achievement has been one of the major milestones in GLIOMARK project.
See here the related press release.